Cargando…

Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro

Diabetes affects at least 285 million people globally, and this number continues to increase. Clinical complications include impaired glucose metabolism, hyperglycemia, dyslipidemia, atherosclerosis and non-alcoholic fatty liver disease. Evidence has shown that natural phenolics play a protective ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Christman, Lindsey M., Dean, Lisa L., Allen, Jonathan C., Godinez, Sofia Feng, Toomer, Ondulla T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436756/
https://www.ncbi.nlm.nih.gov/pubmed/30917157
http://dx.doi.org/10.1371/journal.pone.0214591
_version_ 1783406855302676480
author Christman, Lindsey M.
Dean, Lisa L.
Allen, Jonathan C.
Godinez, Sofia Feng
Toomer, Ondulla T.
author_facet Christman, Lindsey M.
Dean, Lisa L.
Allen, Jonathan C.
Godinez, Sofia Feng
Toomer, Ondulla T.
author_sort Christman, Lindsey M.
collection PubMed
description Diabetes affects at least 285 million people globally, and this number continues to increase. Clinical complications include impaired glucose metabolism, hyperglycemia, dyslipidemia, atherosclerosis and non-alcoholic fatty liver disease. Evidence has shown that natural phenolics play a protective effect on both the development and management of type 2 diabetes. This study evaluated effects of the extract from peanut skins containing polyphenols on induced- hyperglycemia using in vivo and in vitro methods. A human hepatocellular liver carcinoma cell line (HepG2) was used to investigate the effect of the peanut skin extract on cell viability after exposure to high glucose concentrations. In vivo, the effect of peanut skin extract on an oral glucose tolerance was investigated in human subjects. Fifteen participants aged 21–32 underwent an oral glucose tolerance test with five treatments: 1) 50-gram glucose solution (reference); 2). 50-gram glucose solution, followed by 12 mg of vegi-capsulated maltodextrin; 3) 50-gram glucose solution, followed by 120 mg of vegi-capsulated maltodextrin-encapsulated peanut skin extract; 4). 50-gram glucose solution, followed by 28 grams of unfortified coated peanuts; 5) 50-gram glucose solution, followed by 28 grams of chili lime coated peanuts fortified with encapsulated peanut skin extract. Glucose levels were measured using a continuous monitor. Peanut skin extract was found to attenuate the decrease in cell viability in high glucose treated HepG2 cells, showing a protective effect against hyperglycemia induced cell death. No difference in the glycemic response area under the curve between any treatments using the tolerance test, but the treatment of the peanut skin extract with the glucose reference resulted in a significantly lower peak blood glucose response at 45 minutes, indicating that it was effective at reducing the glycemic response. The present study shows that the phenolic extract of peanut skins has an antidiabetic effect, further confirming their value as a functional food ingredient.
format Online
Article
Text
id pubmed-6436756
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64367562019-04-12 Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro Christman, Lindsey M. Dean, Lisa L. Allen, Jonathan C. Godinez, Sofia Feng Toomer, Ondulla T. PLoS One Research Article Diabetes affects at least 285 million people globally, and this number continues to increase. Clinical complications include impaired glucose metabolism, hyperglycemia, dyslipidemia, atherosclerosis and non-alcoholic fatty liver disease. Evidence has shown that natural phenolics play a protective effect on both the development and management of type 2 diabetes. This study evaluated effects of the extract from peanut skins containing polyphenols on induced- hyperglycemia using in vivo and in vitro methods. A human hepatocellular liver carcinoma cell line (HepG2) was used to investigate the effect of the peanut skin extract on cell viability after exposure to high glucose concentrations. In vivo, the effect of peanut skin extract on an oral glucose tolerance was investigated in human subjects. Fifteen participants aged 21–32 underwent an oral glucose tolerance test with five treatments: 1) 50-gram glucose solution (reference); 2). 50-gram glucose solution, followed by 12 mg of vegi-capsulated maltodextrin; 3) 50-gram glucose solution, followed by 120 mg of vegi-capsulated maltodextrin-encapsulated peanut skin extract; 4). 50-gram glucose solution, followed by 28 grams of unfortified coated peanuts; 5) 50-gram glucose solution, followed by 28 grams of chili lime coated peanuts fortified with encapsulated peanut skin extract. Glucose levels were measured using a continuous monitor. Peanut skin extract was found to attenuate the decrease in cell viability in high glucose treated HepG2 cells, showing a protective effect against hyperglycemia induced cell death. No difference in the glycemic response area under the curve between any treatments using the tolerance test, but the treatment of the peanut skin extract with the glucose reference resulted in a significantly lower peak blood glucose response at 45 minutes, indicating that it was effective at reducing the glycemic response. The present study shows that the phenolic extract of peanut skins has an antidiabetic effect, further confirming their value as a functional food ingredient. Public Library of Science 2019-03-27 /pmc/articles/PMC6436756/ /pubmed/30917157 http://dx.doi.org/10.1371/journal.pone.0214591 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Christman, Lindsey M.
Dean, Lisa L.
Allen, Jonathan C.
Godinez, Sofia Feng
Toomer, Ondulla T.
Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title_full Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title_fullStr Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title_full_unstemmed Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title_short Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
title_sort peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436756/
https://www.ncbi.nlm.nih.gov/pubmed/30917157
http://dx.doi.org/10.1371/journal.pone.0214591
work_keys_str_mv AT christmanlindseym peanutskinphenolicextractattenuateshyperglycemicresponsesinvivoandinvitro
AT deanlisal peanutskinphenolicextractattenuateshyperglycemicresponsesinvivoandinvitro
AT allenjonathanc peanutskinphenolicextractattenuateshyperglycemicresponsesinvivoandinvitro
AT godinezsofiafeng peanutskinphenolicextractattenuateshyperglycemicresponsesinvivoandinvitro
AT toomerondullat peanutskinphenolicextractattenuateshyperglycemicresponsesinvivoandinvitro